Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet

Maria Teresa Bardella, Mirella Fraquelli, Maurizio Quatrini, Nicoletta Molteni, Paolo Bianchi, Dario Conte

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

The prevalence of hypertransaminasemia and the effect of gluten-free diet (GFD) were evaluated in 158 consecutive adult celiac patients, 127 women and 31 men, aged 18 to 68 years (mean, 32). At diagnosis, 67 patients (42%) had raised aspartate and/or alanine transaminase levels (AST and ALT; mean, 47 IU/L, range, 30 to 190; and 61 IU/L, range, 25 to 470, respectively), whereas 91 patients had normal liver function tests (LFT). Patients with and without hypertransaminasemia were comparable for epidemiological data, body mass index (18.5 vs. 19.6), and severity of intestinal histological involvement. All patients were given a strict GFD and were followed for 1 to 10 years (median, 4). At 1 year, a highly significant improvement in intestinal histology was observed in both groups (P <.0001). In the 67 patients with raised transaminase levels body mass index (BMI) also increased significantly (from 18.5 to 21.0, P <.001), and transaminase levels normalized in 60 (95%). In the other seven cases liver biopsy showed fatty infiltration in two and chronic active hepatitis (CAH) in the other five, related to chronic infection with hepatitis B virus in three and hepatitis C virus in one, and to autoimmune type in the fifth. We conclude that in adult celiac patients elevated serum transaminases are a frequent finding and normalize in most cases after GFD. When they persist, liver biopsy is mandatory to further investigate hepatic involvement, which in our series was mainly attributable to CAH.

Original languageEnglish
Pages (from-to)833-836
Number of pages4
JournalHepatology
Volume22
Issue number3
DOIs
Publication statusPublished - 1995

Fingerprint

Gluten-Free Diet
Abdomen
Transaminases
Chronic Hepatitis
Liver
Body Mass Index
Biopsy
Liver Function Tests
Aspartate Aminotransferases
Alanine Transaminase
Hepatitis B virus
Hepacivirus
Histology
Infection
Serum

ASJC Scopus subject areas

  • Hepatology

Cite this

Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. / Bardella, Maria Teresa; Fraquelli, Mirella; Quatrini, Maurizio; Molteni, Nicoletta; Bianchi, Paolo; Conte, Dario.

In: Hepatology, Vol. 22, No. 3, 1995, p. 833-836.

Research output: Contribution to journalArticle

Bardella, Maria Teresa ; Fraquelli, Mirella ; Quatrini, Maurizio ; Molteni, Nicoletta ; Bianchi, Paolo ; Conte, Dario. / Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. In: Hepatology. 1995 ; Vol. 22, No. 3. pp. 833-836.
@article{4397fc470c804a259579d4f1e5000a91,
title = "Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet",
abstract = "The prevalence of hypertransaminasemia and the effect of gluten-free diet (GFD) were evaluated in 158 consecutive adult celiac patients, 127 women and 31 men, aged 18 to 68 years (mean, 32). At diagnosis, 67 patients (42{\%}) had raised aspartate and/or alanine transaminase levels (AST and ALT; mean, 47 IU/L, range, 30 to 190; and 61 IU/L, range, 25 to 470, respectively), whereas 91 patients had normal liver function tests (LFT). Patients with and without hypertransaminasemia were comparable for epidemiological data, body mass index (18.5 vs. 19.6), and severity of intestinal histological involvement. All patients were given a strict GFD and were followed for 1 to 10 years (median, 4). At 1 year, a highly significant improvement in intestinal histology was observed in both groups (P <.0001). In the 67 patients with raised transaminase levels body mass index (BMI) also increased significantly (from 18.5 to 21.0, P <.001), and transaminase levels normalized in 60 (95{\%}). In the other seven cases liver biopsy showed fatty infiltration in two and chronic active hepatitis (CAH) in the other five, related to chronic infection with hepatitis B virus in three and hepatitis C virus in one, and to autoimmune type in the fifth. We conclude that in adult celiac patients elevated serum transaminases are a frequent finding and normalize in most cases after GFD. When they persist, liver biopsy is mandatory to further investigate hepatic involvement, which in our series was mainly attributable to CAH.",
author = "Bardella, {Maria Teresa} and Mirella Fraquelli and Maurizio Quatrini and Nicoletta Molteni and Paolo Bianchi and Dario Conte",
year = "1995",
doi = "10.1016/0270-9139(95)90305-4",
language = "English",
volume = "22",
pages = "833--836",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet

AU - Bardella, Maria Teresa

AU - Fraquelli, Mirella

AU - Quatrini, Maurizio

AU - Molteni, Nicoletta

AU - Bianchi, Paolo

AU - Conte, Dario

PY - 1995

Y1 - 1995

N2 - The prevalence of hypertransaminasemia and the effect of gluten-free diet (GFD) were evaluated in 158 consecutive adult celiac patients, 127 women and 31 men, aged 18 to 68 years (mean, 32). At diagnosis, 67 patients (42%) had raised aspartate and/or alanine transaminase levels (AST and ALT; mean, 47 IU/L, range, 30 to 190; and 61 IU/L, range, 25 to 470, respectively), whereas 91 patients had normal liver function tests (LFT). Patients with and without hypertransaminasemia were comparable for epidemiological data, body mass index (18.5 vs. 19.6), and severity of intestinal histological involvement. All patients were given a strict GFD and were followed for 1 to 10 years (median, 4). At 1 year, a highly significant improvement in intestinal histology was observed in both groups (P <.0001). In the 67 patients with raised transaminase levels body mass index (BMI) also increased significantly (from 18.5 to 21.0, P <.001), and transaminase levels normalized in 60 (95%). In the other seven cases liver biopsy showed fatty infiltration in two and chronic active hepatitis (CAH) in the other five, related to chronic infection with hepatitis B virus in three and hepatitis C virus in one, and to autoimmune type in the fifth. We conclude that in adult celiac patients elevated serum transaminases are a frequent finding and normalize in most cases after GFD. When they persist, liver biopsy is mandatory to further investigate hepatic involvement, which in our series was mainly attributable to CAH.

AB - The prevalence of hypertransaminasemia and the effect of gluten-free diet (GFD) were evaluated in 158 consecutive adult celiac patients, 127 women and 31 men, aged 18 to 68 years (mean, 32). At diagnosis, 67 patients (42%) had raised aspartate and/or alanine transaminase levels (AST and ALT; mean, 47 IU/L, range, 30 to 190; and 61 IU/L, range, 25 to 470, respectively), whereas 91 patients had normal liver function tests (LFT). Patients with and without hypertransaminasemia were comparable for epidemiological data, body mass index (18.5 vs. 19.6), and severity of intestinal histological involvement. All patients were given a strict GFD and were followed for 1 to 10 years (median, 4). At 1 year, a highly significant improvement in intestinal histology was observed in both groups (P <.0001). In the 67 patients with raised transaminase levels body mass index (BMI) also increased significantly (from 18.5 to 21.0, P <.001), and transaminase levels normalized in 60 (95%). In the other seven cases liver biopsy showed fatty infiltration in two and chronic active hepatitis (CAH) in the other five, related to chronic infection with hepatitis B virus in three and hepatitis C virus in one, and to autoimmune type in the fifth. We conclude that in adult celiac patients elevated serum transaminases are a frequent finding and normalize in most cases after GFD. When they persist, liver biopsy is mandatory to further investigate hepatic involvement, which in our series was mainly attributable to CAH.

UR - http://www.scopus.com/inward/record.url?scp=0029148357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029148357&partnerID=8YFLogxK

U2 - 10.1016/0270-9139(95)90305-4

DO - 10.1016/0270-9139(95)90305-4

M3 - Article

VL - 22

SP - 833

EP - 836

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -